Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Background Hims 2025 revenue guidance has raised concerns that its become over-reliant on compounded semaglutide Critics question the sustainability of this business model now that the FDA has ended the semaglutide shortage On February 24, Hims & Hers management released aggressive full year guidance for 2025 that assumed $2.3-2.4 billion in revenue, an increase of nearly 60 percent compared to the prior year
The idea of lifestyle change as a treatment for obesity also dates back to Hippocrates
Participants given efinopegdutide showed a dose-dependent increase in body weight loss of 6.7 to 10.0% (placebo subtracted)
Some doctors just simply dont have the time to commit to proper patient management with this drug
But the medication cost itself is non-refundable once shipped
If youve experienced sudden vision loss, blind spots, or difficulty seeing after taking Ozempic, Wegovy, or similar medications, TruLaw can help you explore your legal options
